MarketCap
Facebook
X
TelegramEyeGate Pharmaceuticals, Inc. P/S 2011-2026 | EYEG
P/S Jährlich EyeGate Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.39 K | 6.8 | 10.5 | 38.5 | 23.6 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.39 K | 6.8 | 495 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Alector
ALEC
|
11.7 | $ 2.08 | -14.4 % | $ 214 M |  USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Altimmune
ALT
|
23.1 K | $ 4.2 | -2.67 % | $ 298 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.24 | -3.44 % | $ 2.55 B | USA |
 |
Aptorum Group Limited
APM
|
105 | $ 0.8 | 1.87 % | $ 4.36 M |  China |
 |
Aptevo Therapeutics
APVO
|
3.11 | $ 7.2 | -1.64 % | $ 1.99 M | USA |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | China |
 |
Aquestive Therapeutics
AQST
|
4.2 | $ 4.1 | 2.37 % | $ 356 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
2.83 | $ 8.35 | 1.46 % | $ 225 M |  Israel |
 |
Ardelyx
ARDX
|
3.98 | $ 6.37 | -2.75 % | $ 1.54 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
argenx SE
ARGX
|
311 | $ 756.71 | -1.33 % | $ 25 B |  Niderland |
 |
Armata Pharmaceuticals
ARMP
|
110 | $ 10.91 | 1.58 % | $ 394 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 25.33 | -6.1 % | $ 3.22 B | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arvinas
ARVN
|
3.31 | $ 12.97 | -2.3 % | $ 920 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 61.74 | -2.42 % | $ 8.26 B | USA |
 |
Ascendis Pharma A/S
ASND
|
947 | $ 231.56 | -0.83 % | $ 5 B |  Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.39 | -1.63 % | $ 8.16 B |  Australia |
 |
Actinium Pharmaceuticals
ATNM
|
2.57 K | $ 1.17 | -0.85 % | $ 35.2 M | USA |
 |
Atossa Therapeutics
ATOS
|
4.2 K | $ 4.39 | -0.9 % | $ 553 M | USA |
 |
Atara Biotherapeutics
ATRA
|
0.395 | $ 5.01 | -7.47 % | $ 37.5 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
24.1 | $ 14.14 | -0.21 % | $ 1.9 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.68 | -1.75 % | $ 429 M | Britain |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | Canada |
 |
Atea Pharmaceuticals
AVIR
|
2.11 | $ 4.69 | 0.21 % | $ 395 M | USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Axon Enterprise
AXON
|
19.1 | $ 570.5 | 5.18 % | $ 43.2 B | USA |
 |
Axsome Therapeutics
AXSM
|
13.6 | $ 162.28 | -0.98 % | $ 8.07 B | USA |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.56 | -0.58 % | $ 16.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |